{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:32:51Z","timestamp":1787315571787,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["16\/2551-0000281-9"],"award-info":[{"award-number":["16\/2551-0000281-9"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12035-016-0275-7","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T03:07:59Z","timestamp":1479092879000},"page":"7824-7837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Potentiation of Paclitaxel-Induced Pain Syndrome in Mice by Angiotensin I Converting Enzyme Inhibition and Involvement of Kinins"],"prefix":"10.1007","volume":"54","author":[{"given":"Indiara","family":"Brusco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssia Regina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"de Campos Velho Gewehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Karine","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"La Rocca Tamiozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Fortes","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerusa Duarte","family":"Dalmolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"de Almeida Cabrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vin\u00edcius","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Marchesan","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"key":"275_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","volume":"76","author":"E Gornstein","year":"2014","unstructured":"Gornstein E, Schwarz TL (2014) The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions. Neuropharmacology 76:175\u2013183. doi:\n10.1016\/j.neuropharm.2013.08.016","journal-title":"Neuropharmacology"},{"key":"275_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","volume":"29","author":"CL Loprinzi","year":"2011","unstructured":"Loprinzi CL, Reeves BN, Dakhil SR et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29:1472\u20131478. doi:\n10.1200\/JCO.2010.33.0308","journal-title":"J Clin Oncol"},{"key":"275_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/clpt.2011.115","volume":"90","author":"DR Pachman","year":"2011","unstructured":"Pachman DR, Barton DL, Watson JC, Loprinzi CL (2011) Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther 90:377\u2013387. doi:\n10.1038\/clpt.2011.115","journal-title":"Clin Pharmacol Ther"},{"key":"275_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PPO.0b013e31815a999b","volume":"13","author":"CL Loprinzi","year":"2007","unstructured":"Loprinzi CL, Maddocks-Christianson K, Wolf SL et al (2007) The paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 13:399\u2013403. doi:\n10.1097\/PPO.0b013e31815a999b","journal-title":"Cancer J"},{"key":"275_CR5","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1002\/cncr.27489","volume":"118","author":"BN Reeves","year":"2012","unstructured":"Reeves BN, Dakhil SR, Sloan JA et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy. Cancer 118:5171\u20135178. doi:\n10.1002\/cncr.27489","journal-title":"Cancer"},{"key":"275_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","volume":"10","author":"M Sisignano","year":"2014","unstructured":"Sisignano M, Baron R, Scholich K, Geisslinger G (2014) Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 10:694\u2013707. doi:\n10.1038\/nrneurol.2014.211","journal-title":"Nat Rev Neurol"},{"key":"275_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","volume":"94","author":"RC Polomano","year":"2001","unstructured":"Polomano RC, Mannes AJ, Clark U, Bennet GJ (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94:293\u2013304. doi:\n10.1016\/S0304-3959(01)00363-3","journal-title":"Pain"},{"key":"275_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pbb.2013.10.014","volume":"114-115","author":"FK Rigo","year":"2013","unstructured":"Rigo FK, Dalmolin GD, Trevisan G et al (2013) Effect of \u03c9-conotoxin MVIIA and Ph\u03b11\u03b2 on paclitaxel-induced acute and chronic pain. Pharmacol Biochem Behav 114-115:16\u201322. doi:\n10.1016\/j.pbb.2013.10.014","journal-title":"Pharmacol Biochem Behav"},{"key":"275_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jpain.2009.04.006.Chemotherapy-induced","volume":"10","author":"CC Reyes-Gibby","year":"2009","unstructured":"Reyes-Gibby CC, Morrow PK, Buzdar A, Shete S (2009) Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain 10:1146\u20131150. doi:\n10.1016\/j.jpain.2009.04.006.Chemotherapy-induced","journal-title":"J Pain"},{"key":"275_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","volume":"129","author":"PA Ganz","year":"2011","unstructured":"Ganz PA, Habel LA, Weltzien EK et al (2011) Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat 129:549\u2013556. doi:\n10.1007\/s10549-011-1505-3","journal-title":"Breast Cancer Res Treat"},{"key":"275_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7150\/jca.6888","volume":"4","author":"YK Chae","year":"2013","unstructured":"Chae YK, Brown EN, Lei X et al (2013) Use of ACE inhibitors and angiotensin receptor blockers and primary breast cancer outcomes. J Cancer 4:549\u2013556. doi:\n10.7150\/jca.6888","journal-title":"J Cancer"},{"key":"275_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pain.2008.12.032","volume":"142","author":"M Mos de","year":"2009","unstructured":"de Mos M, Huygen FJPM, Stricker BHC et al (2009) The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 142:218\u2013224. doi:\n10.1016\/j.pain.2008.12.032","journal-title":"Pain"},{"key":"275_CR13","doi-asserted-by":"publisher","first-page":"d8190","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LAG (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344:d8190. doi:\n10.1136\/bmj.d8190","journal-title":"BMJ"},{"key":"275_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/annrheumdis-2014-205739","volume":"75","author":"CR Silva","year":"2016","unstructured":"Silva CR, Oliveira SM, Hoffmeister C et al (2016) The role of kinin B1 receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents. Ann Rheum Dis 75:260\u2013268. doi:\n10.1136\/annrheumdis-2014-205739","journal-title":"Ann Rheum Dis"},{"key":"275_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1152\/ajpheart.00934.2005","volume":"290","author":"D Biyashev","year":"2007","unstructured":"Biyashev D, Tan F, Chen Z et al (2007) Kallikrein activates bradykinin B2 receptors in the absence of kininogen. Am J Physiol Heart Circ Physiol 290:33\u201335. doi:\n10.1152\/ajpheart.00934.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"275_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3727\/096368915X687778","volume":"24","author":"PD Negraes","year":"2015","unstructured":"Negraes PD, Trujillo CA, Pillat MM et al (2015) Review roles of kinins in the nervous system. Cell Transplant 24:613\u2013623. doi:\n10.3727\/096368915X687778","journal-title":"Cell Transplant"},{"key":"275_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1734-1140(09)70115-X","volume":"61","author":"M Bujalska","year":"2009","unstructured":"Bujalska M, Makulska-Nowak H (2009) Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine-and streptozotocin-induced hyperalgesia. Pharmacol Reports 61:631\u2013640. doi:\n10.1016\/S1734-1140(09)70115-X","journal-title":"Pharmacol Reports"},{"key":"275_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1476-5381.2011.01408.x","volume":"164","author":"R Costa","year":"2011","unstructured":"Costa R, Motta EM, Dutra RC et al (2011) Anti-nociceptive effect of kinin B 1 and B 2 receptor antagonists on peripheral neuropathy induced by paclitaxel in mice. Br J Pharmacol 164:681\u2013693. doi:\n10.1111\/j.1476-5381.2011.01408.x","journal-title":"Br J Pharmacol"},{"key":"275_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0028-3908(01)00142-3","volume":"41","author":"J Ferreira","year":"2001","unstructured":"Ferreira J, Campos MM, Arau RC, Bader M (2001) Evidence for the participation of kinins in Freund \u2019 s adjuvant- induced inflammatory and nociceptive responses in kinin B 1 and B 2 receptor knockout mice. Neuropharmacology 41:1006\u20131012. doi:\n10.1016\/S0028-3908(01)00142-3","journal-title":"Neuropharmacology"},{"key":"275_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109\u2013110. doi:\n10.1016\/0304-3959(83)90201-4","journal-title":"Pain"},{"key":"275_CR21","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM et al (2010) Editorial: guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160:1573\u20131576. doi:\n10.1111\/j.1476-5381.2010.00873.x","journal-title":"Br J Pharmacol"},{"key":"275_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2007.11.008","volume":"54","author":"J Ferreira","year":"2008","unstructured":"Ferreira J, Trich\u00eas KM, Medeiros R et al (2008) The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice. Neuropharmacology 54:597\u2013604. doi:\n10.1016\/j.neuropharm.2007.11.008","journal-title":"Neuropharmacology"},{"key":"275_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bjp.0705546","volume":"141","author":"J Ferreira","year":"2004","unstructured":"Ferreira J, da Silva GL, Calixto JB (2004) Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 141:787\u2013794. doi:\n10.1038\/sj.bjp.0705546","journal-title":"Br J Pharmacol"},{"key":"275_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S0028-3908(02)00311-8","volume":"43","author":"J Ferreira","year":"2002","unstructured":"Ferreira J, Campos MM, Ara\u00fajo R et al (2002) The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology 43:1188\u20131197. doi:\n10.1016\/S0028-3908(02)00311-8","journal-title":"Neuropharmacology"},{"key":"275_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW et al (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363. doi:\n10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"key":"275_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejphar.2011.10.001","volume":"672","author":"SM Oliveira","year":"2011","unstructured":"Oliveira SM, Drewes CC, Silva CR et al (2011) Involvement of mast cells in a mouse model of postoperative pain. Eur J Pharmacol 672:88\u201395. doi:\n10.1016\/j.ejphar.2011.10.001","journal-title":"Eur J Pharmacol"},{"key":"275_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/ALN.0b013e31827d415f","volume":"118","author":"SM Oliveira","year":"2013","unstructured":"Oliveira SM, Silva CR, Ferreira J (2013) Critical role of protease-activated receptor 2 activation by mast cell tryptase in the development of postoperative pain. Anesthesiology 118:679\u2013690. doi:\n10.1097\/ALN.0b013e31827d415f","journal-title":"Anesthesiology"},{"key":"275_CR28","doi-asserted-by":"publisher","first-page":"e2198","DOI":"10.1371\/journal.pntd.0002198","volume":"7","author":"C Gewehr","year":"2013","unstructured":"Gewehr C, Oliveira SM, Rossato MF et al (2013) Mechanisms involved in the nociception triggered by the venom of the armed spider Phoneutria nigriventer. PLoS Negl Trop Dis 7:e2198. doi:\n10.1371\/journal.pntd.0002198","journal-title":"PLoS Negl Trop Dis"},{"key":"275_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. doi:\n10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"275_CR30","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered by paclitaxel (Taxol). Semin Oncol 20:1\u201315","journal-title":"Semin Oncol"},{"key":"275_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pain.2005.06.001","volume":"117","author":"J Ferreira","year":"2005","unstructured":"Ferreira J, Trich\u00eas KM, Medeiros R, Calixto JB (2005) Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice. Pain 117:171\u2013181. doi:\n10.1016\/j.pain.2005.06.001","journal-title":"Pain"},{"key":"275_CR32","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/nn1804","volume":"9","author":"J Lai","year":"2006","unstructured":"Lai J, Luo M-C, Chen Q et al (2006) Dynorphin a activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 9:1534\u20131540. doi:\n10.1038\/nn1804","journal-title":"Nat Neurosci"},{"key":"275_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2007.04.013","volume":"53","author":"MFP Werner","year":"2007","unstructured":"Werner MFP, Kassuya CAL, Ferreira J et al (2007) Peripheral kinin B1 and B2 receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology 53:48\u201357. doi:\n10.1016\/j.neuropharm.2007.04.013","journal-title":"Neuropharmacology"},{"key":"275_CR34","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.pain.2013.08.028","volume":"154","author":"C Geber","year":"2013","unstructured":"Geber C, Breimhorsta M, Burbacha B et al (2013) Pain in chemotherapy-induced neuropathy--more than neuropathic? Pain 154:2877\u20132887. doi:\n10.1016\/j.pain.2013.08.028","journal-title":"Pain"},{"key":"275_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/cncr.24870","volume":"116","author":"SL Moulder","year":"2010","unstructured":"Moulder SL, Holmes FA, Tolcher AW et al (2010) A randomized phase 2 trial comparing 3-h versus 96-h infusion schedules of paclitaxel for the treatment of metastatic breast cancer. Cancer 116:814\u2013821. doi:\n10.1002\/cncr.24870","journal-title":"Cancer"},{"key":"275_CR36","doi-asserted-by":"publisher","first-page":"e80915","DOI":"10.1371\/journal.pone.0080915","volume":"8","author":"L Meyer","year":"2013","unstructured":"Meyer L, Patte-Mensah C, Taleb O, Mensah-Nyagan AG (2013) Neurosteroid 3\u03b1-Androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms. PLoS One 8:e80915. doi:\n10.1371\/journal.pone.0080915","journal-title":"PLoS One"},{"key":"275_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)02658-4","volume":"457","author":"BH Gabra","year":"2002","unstructured":"Gabra BH, Sirois P (2002) Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol 457:115\u2013124","journal-title":"Eur J Pharmacol"},{"key":"275_CR38","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1523\/JNEUROSCI.4389-07.2008","volume":"28","author":"NLM Quint\u00e3o","year":"2008","unstructured":"Quint\u00e3o NLM, Passos GF, Medeiros R et al (2008) Neuropathic pain-like behavior after brachial plexus avulsion in mice: the relevance of kinin B1 and B2 receptors. J Neurosci 28:2856\u20132863. doi:\n10.1523\/JNEUROSCI.4389-07.2008","journal-title":"J Neurosci"},{"key":"275_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000110788","volume":"81","author":"M Bujalska","year":"2008","unstructured":"Bujalska M, Tatarkiewicz J, Gumu\u0142ka SW (2008) Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology 81:158\u2013163. doi:\n10.1159\/000110788","journal-title":"Pharmacology"},{"key":"275_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0028-3908(94)90171-6","volume":"33","author":"MN Perkins","year":"1994","unstructured":"Perkins MN, Kelly D (1994) Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacoly 33:657\u2013660. doi:\n10.1016\/0028-3908(94)90171-6","journal-title":"Neuropharmacoly"},{"key":"275_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0306-4522(95)00280-V","volume":"69","author":"SG Khasar","year":"1995","unstructured":"Khasar SG, Miao FJ, Levine JD (1995) Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat. Neuroscience 69:685\u2013690. doi:\n10.1016\/0306-4522(95)00280-V","journal-title":"Neuroscience"},{"key":"275_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0304-3959(03)00141-6","volume":"104","author":"A Fox","year":"2003","unstructured":"Fox A, Wotherspoon G, McNair K et al (2003) Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104:683\u2013691. doi:\n10.1016\/S0304-3959(03)00141-6","journal-title":"Pain"},{"key":"275_CR43","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.1073\/pnas.120035997","volume":"97","author":"JB Pesquero","year":"2000","unstructured":"Pesquero JB, Araujo RC, Heppenstall PA et al (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 97:8140\u20138145. doi:\n10.1073\/pnas.120035997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"275_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/jpet.105.098368.limit","volume":"318","author":"F Porreca","year":"2006","unstructured":"Porreca F, Vanderah TW, Guo W et al (2006) (LF22-0542), a novel nonpeptidic bradykinin B 1 receptor antagonist. J Pharmacol Exp Ther 318:195\u2013205. doi:\n10.1124\/jpet.105.098368.limit","journal-title":"J Pharmacol Exp Ther"},{"key":"275_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0304-3959(00)00256-6","volume":"86","author":"D Levy","year":"2000","unstructured":"Levy D, Zochodne DW (2000) Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in animal model of neuropathic pain. Pain 86:265\u2013271. doi:\n10.1016\/S0304-3959(00)00256-6","journal-title":"Pain"},{"key":"275_CR46","doi-asserted-by":"publisher","first-page":"16847","DOI":"10.1074\/jbc.M200355200","volume":"277","author":"T Ignjatovic","year":"2002","unstructured":"Ignjatovic T, Tan F, Brovkovych V et al (2002) Novel mode of action of angiotensin I converting enzyme inhibitors. J Biol Chem 277:16847\u201316852. doi:\n10.1074\/jbc.M200355200","journal-title":"J Biol Chem"},{"key":"275_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/HYPERTENSIONAHA.109.144600.Angiotensin","volume":"55","author":"EG Erd\u00f6s","year":"2010","unstructured":"Erd\u00f6s EG, Tan F, Skidgel RA (2010) Angiotensin I\u2013converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55:1\u201312. doi:\n10.1161\/HYPERTENSIONAHA.109.144600.Angiotensin","journal-title":"Hypertension"},{"key":"275_CR48","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1096\/fj.06-6113com","volume":"20","author":"Z Chen","year":"2006","unstructured":"Chen Z, Deddish PA, Minshall RD et al (2006) Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J 20:2261\u20132270. doi:\n10.1096\/fj.06-6113com","journal-title":"FASEB J"},{"key":"275_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1043-6618(02)00319-5","volume":"47","author":"AM Sharifi","year":"2003","unstructured":"Sharifi AM, Akbarloo N, Heshmatian B, Ziai A (2003) Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. Pharmacol Res 47:201\u2013209. doi:\n10.1016\/S1043-6618(02)00319-5","journal-title":"Pharmacol Res"},{"key":"275_CR50","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1158\/0008-5472.CAN-04-2624","volume":"65","author":"E Pasquier","year":"2005","unstructured":"Pasquier E, Honore S, Pourroy B et al (2005) Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in Canc. Cancer Res 65:2433\u20132440. doi:\n10.1158\/0008-5472.CAN-04-2624","journal-title":"Cancer Res"},{"key":"275_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1047-2797(96)00063-4","volume":"6","author":"R Yancik","year":"1996","unstructured":"Yancik R, Havlik RJ, Wesley MN et al (1996) Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 6:399\u2013412. doi:\n10.1016\/S1047-2797(96)00063-4","journal-title":"Ann Epidemiol"},{"key":"275_CR52","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1523\/JNEUROSCI.2466-04.2005","volume":"25","author":"J Ferreira","year":"2005","unstructured":"Ferreira J, Beirith A, Mori MAS et al (2005) Reduced nerve injury-induced neuropathic pain in kinin B 1 receptor knock-out mice. Receptor 25:2405\u20132412. doi:\n10.1523\/JNEUROSCI.2466-04.2005","journal-title":"Receptor"},{"key":"275_CR53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bjp.0706012","volume":"143","author":"JB Calixto","year":"2004","unstructured":"Calixto JB, Medeiros R, Fernandes ES et al (2004) Kinin B 1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143:803\u2013818. doi:\n10.1038\/sj.bjp.0706012","journal-title":"Br J Pharmacol"},{"key":"275_CR54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0306-4522(01)00387-6","volume":"107","author":"QP Ma","year":"2001","unstructured":"Ma QP (2001) The expression of bradykinin B (1) receptors on primary sensory neurones that give rise to small caliber sciatic nerve fibres in rats. Neuroscience 107:665\u2013673","journal-title":"Neuroscience"},{"key":"275_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0166-2236(93)90133-7","volume":"16","author":"A Dray","year":"1993","unstructured":"Dray A, Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99\u2013104. doi:\n10.1016\/0166-2236(93)90133-7","journal-title":"Trends Neurosci"},{"key":"275_CR56","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00001503-200110000-00010","volume":"14","author":"JB Calixto","year":"2001","unstructured":"Calixto JB, Cabrini DA, Ferreira J, Campos MM (2001) Inflammatory pain: kinins and antagonists. Curr Opin Anaesthesiol 14:519\u2013526. doi:\n10.1097\/00001503-200110000-00010","journal-title":"Curr Opin Anaesthesiol"},{"key":"275_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0196-9781(94)90214-3","volume":"15","author":"A D\u00e9carie","year":"1994","unstructured":"D\u00e9carie A (1994) Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 15:511\u2013518. doi:\n10.1016\/0196-9781(94)90214-3","journal-title":"Peptides"},{"key":"275_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1515\/hsz-2012-0290","volume":"394","author":"X Zhang","year":"2013","unstructured":"Zhang X, Tan F, Brovkovych V et al (2013) Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output. Biol Chem 394:335\u2013345. doi:\n10.1515\/hsz-2012-0290","journal-title":"Biol Chem"},{"key":"275_CR59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/HYPERTENSIONAHA.106.085761","volume":"50","author":"DO Sivieri","year":"2007","unstructured":"Sivieri DO, Bispo-da-Silva LB, Oliveira EB et al (2007) Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Hypertension 50:110\u2013115. doi:\n10.1161\/HYPERTENSIONAHA.106.085761","journal-title":"Hypertension"},{"key":"275_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pharmthera.2015.12.006","volume":"162","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Mu X, Du G (2016) Microtubule-stabilizing agents: new drug discovery and cancer therapy. Pharmacol Ther 162:134\u2013143. doi:\n10.1016\/j.pharmthera.2015.12.006","journal-title":"Pharmacol Ther"},{"key":"275_CR61","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1586\/eci.12.67","volume":"8","author":"M Ba\u015f","year":"2012","unstructured":"Ba\u015f M (2012) Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial. Expert Rev Clin Immunol 8:707\u2013717. doi:\n10.1586\/eci.12.67","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0275-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0275-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0275-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T07:39:54Z","timestamp":1510558794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0275-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0275-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}